Thymoma
Definition
- Thymic epithelial cell neoplasm lacking overtly malignant cytologic features
Diagnostic Criteria
- The currently most widely used classification is that of the WHO 2004
- A number of other classifications have been used or proposed
- See individual entries for each type by clicking on the links below
- Type A
- Thymoma composed of bland spindle to oval cells with few to no lymphocytes
- Type AB
- Thymoma with a mixture of lymphocyte-poor and lymphocyte rich areas
- Type B1
- Thymoma exhibiting areas reminiscent of both normal thymic cortex and medulla
- Type B2
- Thymoma with prominent large epithelial cells with an admixture of numerous lymphocytes
- Type B3
- Thymoma composed of sheets of epithelial cells with mild to moderat atypia and scant lymphocytes
- Micronodular Thymoma with Lymphoid Stroma
- Thymoma composed of multiple epithelial nodules surrounded by prominent lymphoid stroma containing mature B and T cells and devoid of epithelial cells
- Metaplastic Thymoma
- Thymoma composed of alternating areas of epithelial cells and bland slender spindle cells
- Combined Thymoma
- A thymoma exhibiting more than one thymoma type pattern, or
- A combination of thymoma and thymic carcinoma
- Malignant Thymoma
- Generally used to refer to any of the above thymoma types that is behaving aggressively
- Thymic carcinoma is the preferred term for a cytologically malignant epithelial thymic neoplasm
Staging
- (Modified Masaoka - there is no official AJCC TNM staging for thymoma)
Stage I |
Grossly and microscopically encapsulated |
Stage IIa |
Microscopic transcapsular invasion into fat |
Stage IIb |
Macroscopic capsular invasion into fat |
Stage III |
Macroscopic invasion of neighboring organs |
Stage IVa |
Pleural or pericardial dissemination |
Stage IVb |
Hematogenous or lymphatic dissemination |
- Lymphatic metastases are rare
- Hematogenous metastases are exceedingly rare
- There is no significant difference in disease free or overall survivall between Stage I and II (Gupta et al.. Arch Pathol Lab Med. 2008 Jun;132(6):926-30.)
Robert V Rouse MD
Department of Pathology
Stanford University School of Medicine
Stanford CA 94305-5342
Updates: July 3, 2008; May 10, 2009; June 20, 2009

